Abstract
State-of-the-art multidetector computed tomography (MDCT) and magnetic resonance (MR) imaging technologies offer detailed insights into the liver’s anatomy and the pathophysiology of liver disease, such that imaging has become the pacemaker in the development of new therapeutic techniques. Understanding different imaging techniques and the diagnostic potential of different modalities, including contrast utilization, is essential to optimize patient diagnoses. In the current environment of cost containment, the most appropriate modality should be chosen to answer the clinical question. Ultrasonography (US) is widely available, non-invasive, and the least expensive, but it is limited by low sensitivity and specificity unless US contrast agents are used. Instead, contrastenhanced CT has emerged as the modality of choice for routine liver imaging while MR imaging is used primarily as a problem-solving technique for liver evaluation when CT or US results are equivocal or if high concern exists for malignancy in certain high-risk populations. This chapter highlights the imaging of hepatic focal liver lesions, focusing on MDCT and MR imaging, but including ultrasonography in selected cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Laghi A (2007) Multidetector CT (64 Slices) of the liver: examination techniques. Eur Radiol 17:675–683
Weg N, Scheer MR, Gabor MP (1998) Liver lesions: improved detection with dual-detector-array CT and routine 2.5-mm thin collimation. Radiology 209:417–426
Ichikawa T, Nakajima H, Nanbu A et al (2006) Effect of injection rate of contrast material on CT of hepatocellular carcinoma. AJR Am J Roentgenol 186:1413–1418
Foley WD, Hoffmann RG, Quiroz FA et al (1994) Hepatic helical CT: contrast material injection protocol. Radiology 192:367–371
Kim T, Murakami T, Takahashi S et al (1998) Effects of injection rates of contrast material on arterial phase hepatic CT. AJR Am J Roentgenol 171:429–432
Schima W, Hammerstingl R, Catalano C et al (2006) Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. AJR Am J Roentgenol 186:1571–1579
Sultana S, Awai K, Nakayama Y et al (2007) Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology 243:140–147
Oliver JH, Baron RL (1996) Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretations, and pitfalls. Radiology 201:1–14
Mehnert F, Pereira PL, Trubenbach J et al (2001) Biphasic spiral CT of the liver: automatic bolus tracking or time delay? Eur Radiol 11:427–431
Oudkerk M, Torres CG, Song B et al (2002) Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 223:517–524
Scharitzer M, Schima W, Schober E et al (2005) Characterization of hepatocellular tumors: value of mangafodipirenhanced magnetic resonance imaging. J Comput Assist Tomogr 29:181–190
Ward J, Robinson PJ, Guthrie JA et al (2005) Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium-and SPIO-enhanced imaging. Radiology 237:170–180
Hammerstingl R, Huppertz A, Breuer J et al (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intra-operative and histopathologic findings in focal liver lesions. Eur Radiol 18:457–467
Schima W, Saini S, Echeverri JA et al (1997) T2-weighted MR imaging for characterization of focal liver lesions: conventional spin-echo vs fast spin-echo. Radiology 202:389–393
Farraher SW, Jara H, Chang KJ et al (2006) Differentiation of hepatocellular carcinoma and hepatic metastasis from cysts and hemangiomas with calculated T2 relaxation times and the T1/T2 relaxation times ratio. J Magn Reson Imaging 24:1333–1341
Semelka RC, Brown ED, Ascher SM et al (1994) Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 192:401–406
Kim T, Federle MP, Baron RL et al (2001) Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 219:699–706
Ba-Ssalamah A, Uffmann M, Saini S et al (2009) Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 19:342–357
Grangier C, Tourniaire J, Mentha G et al (1994) Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles. J Comput Assist Tomogr 18:888–896
Vossen JA, Buijs M, Liapi E et al (2008) Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hyper-vascular liver lesions. J Comput Assist Tomogr 32:750–756
Kehagias D, Moulopoulos L, Antoniou A et al (2001) Focal nodular hyperplasia: imaging findings. Eur Radiol 11:202–212
Brancatelli G, Federle MP, Grazioli L et al (2001) Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 219:61–68
Uggowitzer MM, Kugler C, Mischinger HJ et al (1999) Echoenhanced Doppler sonography of focal nodular hyperplasia of the liver. J Ultrasound Med 18:445–451; quiz 453–444
Ba-Ssalamah A, Schima W, Schmook MT et al (2002) Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. AJR Am J Roentgenol 179:1447–1456
Leconte I, Van Beers BE, Lacrosse M et al (2000) Focal nodular hyperplasia: natural course observed with CT and MRI. J Comput Assist Tomogr 24:61–66
Mathieu D, Kobeiter H, Maison P et al (2000) Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 118:560–564
Prasad SR, Sahani DV, Mino-Kenudson M et al (2008) Benign hepatic neoplasms: an update on cross-sectional imaging spectrum. J Computer Assist Tomogr 32:829–840
Grazioli L, Morana G, Kirchin MA, Schneider G (2005) Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236:166–177
Jeffrey RB, Jr, Tolentino CS, Chang FC, Federle MP (1988) CT of small pyogenic hepatic abscesses: the cluster sign. AJR Am J Roentgenol 151:487–489
Barreda R, Ros PR (1992) Diagnostic imaging of liver abscess. Crit Rev Diagn Imaging 33:29–58
Laghi A, Iannaccone R, Rossi P et al (2003) Hepatocellular carcinoma: detection with triple-phase multi-detector row helical CT in patients with chronic hepatitis. Radiology 226:543–549
Ichikawa T, Kitamura T, Nakajima H et al (2002) Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver? AJR Am J Roentgenol 179:751–758
Monzawa S, Ichikawa T, Nakajima H et al (2007) Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR Am J Roentgenol 188:147–153
Iannacone R, Laghi A, Catalano C et al (2005) Hepatocellular carcinoma: Role of unenhanced and delayed-phase multi-detector row helical CT in patients with cirrhosis. Radiology 234:460–467
Baron RL, Brancatelli G (2004) Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 127:s133–143
Forner A, Vilana R, Ayuso C et al (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology (Baltimore, Md) 47:97–104
Tublin ME, Dodd GD, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 168:719–723
Stevens WR, Gulino SP, Batts KP et al (1996) Mosaic pattern of hepatocellular carcinoma: histologic basis for a characteristic CT appearance. J Comput Assist Tomogr 20:337–342
Pauleit D, Textor J, Bachmann R et al (2001) Hepatocellular carcinoma: detection with gadolinium-and ferumoxidesenhanced MR imaging of the liver. Radiology 222:73–80
Tang Y, Yamashita Y, Arakawa A et al (1999) Detection of hepatocellular carcinoma arising in cirrhotic livers: Comparison of gadolinium-and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol 172:1547–1554
Kitao A, Zen Y, Matsui O et al (2009) Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography-radiologic-pathologic correlation. Radiology 252:605–614
Ward J, Guthrie JA, Scott DJ et al (2000) Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 216:154–162
Lee DH, Kim SH, Lee JM et al (2009) Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dualcontrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings. Invest Radiol 44:311–321
Ichikawa T, Federle MP, Grazioli L et al (1999) Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology 213:352–361
Ichikawa T, Federle MP, Grazioli L, Marsh W (2000) Fibrolamellar hepatocellular carcinoma: pre-and posttherapy evaluation with CT and MR imaging. Radiology 217:145–151
Lim JH (2003) Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 181:819–827
Han JK, Choi BI, Kim AY et al (2002) Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radio-graphics 22:173–187
Lee WJ, Lim HK, Jang KM et al (2001) Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 21 Spec No:S97–S116
Buetow PC, Buck JL, Pantongrag-Brown L et al (1995) Biliary cystadenoma and cystadenocarcinoma: clinical-imagingpathologic correlations with emphasis on the importance of ovarian stroma. Radiology 196:805–810
Peterson MS, Baron RL, Rankin SC (2000) Hepatic angiosarcoma: findings on multiphasic contrast-enhanced helical CT do not mimic hepatic hemangioma. AJR Am J Roentgenol 175:165–170
Koyama T, Fletcher JG, Johnson CD et al (2002) Primary hepatic angiosarcoma: findings at CT and MR imaging. Radiology 222:667–673
Miller WJ, Dodd GD 3rd, Federle MP, Baron RL (1992) Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol 159:53–57
Schima W, Kulinna C, Langenberger H, Ba-Ssalamah A (2005) Liver metastases of colorectal cancer: US, CT or MR? Cancer Imaging 5 Spec No A:S149–156
Lee MJ, Saini S, Compton CC, Malt RA (1991) MR demonstration of edema adjacent to a liver metastasis: pathologic correlation. AJR Am J Roentgenol 157:499–501
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Verlag Italia
About this chapter
Cite this chapter
Schima, W., Baron, R. (2010). Focal Liver Lesions. In: Hodler, J., Zollikofer, C.L., Von Schulthess, G.K. (eds) Diseases of the Abdomen and Pelvis 2010–2013. Springer, Milano. https://doi.org/10.1007/978-88-470-1637-8_9
Download citation
DOI: https://doi.org/10.1007/978-88-470-1637-8_9
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1636-1
Online ISBN: 978-88-470-1637-8
eBook Packages: MedicineMedicine (R0)